CDKN1A and cancer: Besides regulation of various cellular mechanisms, which are meant to prevent or stop the initiation or progression of cancer cell development, p53 mediates transcriptional activation and further upregulation of cyclin-dependent kinase inhibitor 1A (CDKN1A/p21).